Inhibitory effects of the class III antiarrhythmic drug amiodarone on cloned HERG potassium channels

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 359, Issue 3, 1999, Pages 212-219

  Kiehn, Johann ^a   Thomas, Dierk ^a   Karle, Christoph A ^a   Schöls, Wolfgang ^a   Kübler, Wolfgang ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

'Torsade de pointes'; Amiodarone; Arrhythmia; Class III antiarrhythmic drug; Delayed rectifier; HERG; Potassium channel

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; POTASSIUM CHANNEL;

ANIMAL CELL; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CHANNEL GATING; DRUG EFFECT; DRUG MECHANISM; HEART ARRHYTHMIA; NONHUMAN; OOCYTE; POTASSIUM CURRENT; VOLTAGE CLAMP;

EID: 0033026763     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005344     Document Type: Article

References (32)

1. Baiser JR, Bennett PB, Hondeghem LM, Roden DM (1991) Suppression of time-dependent outward current in guinea pig ventricular myocytes. Circ Res 69:519-529
2. Busch AE, Eigenberger B, Jurkiewicz NK, Salata JJ, Pica A, Suessbrich H, Lang F (1998) Blockade of HERG channels by the class III antiarrhythmic azimilide: mode of action. Br J Pharmacol 123:23-30
3. Carmeliet E (1993a) Mechanisms and control of repolarization. Eur Heart J 14 [Suppl H]:3-13
4. Carmeliet E (1993b) Use-dependent block of the delayed K-current in rabbit ventricular myocytes. Cardiovasc Drug Ther 7:599-604
5. Ceremuzynski L, Kleczar E, Kremisnska-Pakula M, et al (1992) Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled pilot study. J Am Coll Cardiol 20:1063-1065
6. Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R (1994) Randomised trial of low-dose amiodarone in severe congestive heart failure. Lancet 344:493-498
7. Fromenty B, Fisch C, Berson A, Letteron P, Larrey D, Pessayre D (1990) Dual effect of amiodarone on mitochondrial respiration. Initial protonophoric uncoupling effect followed by inhibition of the respiratory chain at the levels of complex I and complex II. J Pharmacol Exp Ther 255:1377-1384
8. Haffajee CI, Love JC, Alpert JS, Asdourian GK, Sloan KC (1983) Efficacy and safety of long-term amiodarone in treatment of cardiac arrhythmias: dosage experience. Am Heart J 106:935-943
9. Herbette LG, Trumbore M, Chester DW, Katz AM (1988) Possible molecular basis for the pharmacokinetics and pharmacodynamics of three membrane-active drugs: propanolol, nimodipine and amiodarone. J Mol Cell Cardiol 20:373-378
10. Hohnloser SH, Klingenheben T, Singh BN (1994) Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia. Ann Intern Med 121:529-535
11. Hondeghem LM, Snyders DJ (1990) Class III antiarrhythmic agents have a lot of potential but a long way to go - reduced effectiveness and dangers of reverse use dependence. Circulation 81:686-690
12. Kr. Circulation 94:2938-2946
13. Kamiya M, Cheng J, Kodama I, Toyama J (1995) Acute and chronic effects of amiodarone on action potential and ionic currents in single rabbit ventricular myocytes. In: Recent progress in electrophysiology of heart. CRC Press, Boca Raton, pp 139-149
14. Kiehn J, Lacerda AE, Wible B, Brown AM (1996) Molecular physiology and pharmacology of HERG. Single channel currents and block by dofetilide. Circulation 94:2572-2579
15. Kodama I, Kamiya K, Toyama J (1997) Cellular electropharmacology of amiodarone. Review. Cardiovasc Res 35:13-29
16. Mason JW (1987) Amiodarone. N Engl J Med 316:455-466
17. Mason JW, Hondeghem LM, Katzung BG (1984) Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone. Circ Res 55:277-287
18. Pfisterer ME, Kiowski W, Brunner H (1993) Long-term benefit of 1-year amiodarone treatment for persistent complex ventricular arrhythmias after myocardial infarction. Circulation 87:309-311
19. Polster P, Broeckhuysen J (1976) The adrenergic antagonism of amiodarone. Biochem Pharmacol 25:133-140
20. Kr potassium channel. Cell 81:1-20
21. Sanguinetti MC, Curran ME, Spector PS, Keating MT (1996) Spectrum of HERG K-channel dysfunction in an inherited cardiac arrhythmia. Proc Natl Acad Sci USA 93:2208-2212
22. Smith P, Baukrowitz T, Yellen G (1996) The inward rectification mechanism of the HERG cardiac potassium channel. Nature 379:833-836
23. + channel. Circ Res 78:499-503
24. Kr channel. J Gen Physiol 107:611-619
25. Suessbrich H, Schönherr R, Heinemann SH, Lang F, Busch AE (1997a) Specific block of cloned HERG channels by clofilium and its tertiary analog LY97241. FEBS Lett 414:435-438
26. Suessbrich H, Schönherr R, Heinemann SH, Attali B, Lang F, Busch AE (1997b) The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes. Br J Pharmacol 120:968-974
27. Trudeau MC, Warmke JW, Ganetzky B, Robertson GA (1995) HERG, a human inward rectifier in the voltage gated potassium channel family. Science 269:92-95
28. Trumbore M, Chester DW, Moring J, Rhodes D, Herbette LG (1988) Structure and location of amiodarone in a membrane bilayer as determined by molecular mechanics and quantitative x-ray diffraction. Biophys J 54:535-543
29. Varro A, Virag L, Papp JG (1996) Comparison of the chronic and acute effects of amiodarone on the calcium and potassium currents in rabbit isolated myocytes. Br J Pharmacol 117:1181-1186
30. Waldo AL, Camm AJ, deRuyter H, Freidman PL, MacNeil DJ, Pitt B, Pratt CM, Rodda BE, Schwartz PJ (1996) Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 348:7-12
31. Yabek S, Kato R, Singh B (1986) Acute electrophysiological effects of amiodarone and desethylamiodarone in isolated cardiac muscle. J Cardiovasc Pharmacol 6:197-207
32. Yang T, Prakash C, Roden DM, Snyders DJ (1995) Mechanism of block of a human cardiac potassium channel by terfenadine racemate and enantiomers. Br J Pharmacol 115:267-274